ampicillin- ampicillin sodium injection, powder, for solution
general injectables & vaccines, inc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd) - ampicillin 500 mg in 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of ampicillin and other antibacterial drugs, ampicillin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ampicillin is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: respiratory tract infections caused by s. pneumoniae (formerly d. pneumoniae), staphylococcus aureus (penicillinase and non-penicillinase producing), h. influenzae and group a beta-hemolytic streptococci. bacterial meningitis caused by e. coli, group b streptococci, and other gram-negative bacteria (listeria monocytogenes, n. meningitidis).
ampicillin sodium injection, powder, for solution
mylan institutional llc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd) - ampicillin 10 g in 100 ml - ampicillin for injection, usp is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the following conditions: respiratory tract infections caused by streptococcus pneumoniae , staphylococcus aureus (penicillinase and nonpenicillinase-producing), h. influenzae , and group a beta-hemolytic streptococci. bacterial meningitis caused by e. coli , group b streptococci, and other gram-negative bacteria (listeria monocytogenes, n. meningitidis ). the addition of an aminoglycoside with ampicillin may increase its effectiveness against gram-negative bacteria. septicemia and endocarditis caused by susceptible gram-positive organisms including streptococcus spp., penicillin g-susceptible staphylococci, and enterococci. gram-negative sepsis caused by e. coli, proteus mirabilis and salmonella spp. responds to ampicillin. endocarditis due to enterococcal strains usually respond to intravenous therapy. the addition of an aminoglycoside may enhance the effectiveness of
ampicillin 250 mg/5ml syrup
regent laboratories limited - ampicillin trihydrate - syrup - 250 mg/5ml
ampicillin 125 mg/5ml syrup
regent laboratories limited - ampicillin trihydrate - syrup - 125 mg/5ml
ampicillin 500 milligram capsules hard
athlone laboratories ltd - ampicillin trihydrate - capsules hard - 500 milligram
ampicillin 250 milligram capsules hard
athlone laboratories ltd - ampicillin trihydrate - capsules hard - 250 milligram
ampicillin oral suspension bp 250 mg/5ml granules for oral suspension
athlone laboratories ltd - ampicillin trihydrate - granules for oral suspension - 250 mg/5ml
ampicillin oral suspension bp 125 mg/5ml granules for oral suspension
athlone laboratories ltd - ampicillin trihydrate - granules for oral suspension - 125 mg/5ml
ampicillin 250mg capsules
kent pharma (uk) ltd - ampicillin - oral capsule - 250mg
ampicillin 500mg capsules
a a h pharmaceuticals ltd - ampicillin - oral capsule - 500mg